Science

Microneedling, also called collagen induction therapy (CIT) or percutaneous collagen induction (PCI), works by creating thousands of controlled micro-channels in the epidermis and upper dermis. Each micro-injury initiates the skin's wound-healing cascade: inflammation, proliferation, and remodeling.
 

During the remodeling phase, fibroblasts up-regulate production of type I and type III collagen along with elastin and glycosaminoglycans. Across repeated sessions, that remodeling accumulates — thickening the dermis and restructuring the extracellular matrix.

What determines the clinical response

• Needle depth. 0.25–0.5 mm affects the stratum corneum and upper epidermis, useful primarily for topical absorption. 1.0–1.5 mm reaches the papillary and reticular dermis, where meaningful collagen remodeling occurs. Depth should be matched to the skin location and the indication. 
• Needle gauge and count. Finer gauges create cleaner channels with less crush injury to surrounding tissue. Higher-count cartridges distribute load at the cost of requiring more controlled passes.
• - Oscillation frequency. Automated pens oscillate at 100+ cycles per second, producing uniform channels with a fraction of the tissue drag of a manual roller.
• Session frequency. Four to six weeks between deeper sessions allows the remodeling phase to complete. More frequent deep sessions interrupt the cycle.
• Expected response timeline
• Erythema resolves in 12–48 hours depending on depth. Initial textural change appears in 2–4 weeks. Collagen remodeling is slower — meaningful improvement is typically assessed at 8–12 weeks and continues to accumulate through six months of consistent protocol. 
•  Microneedling is supported by peer-reviewed evidence for acne scarring, photoaging, hypertrophic scars, and androgenetic alopecia (in combination with appropriate topicals). Full study citations are on the Evidence page.